Dyslipidemia: evidence of efficacy of the pharmacological and non-pharmacological treatment in the elderly. J Geriatr Cardiol 2012; 9(2):83-90.Dyslipidemia: evidence of efficacy of the pharmacological and non-p
Pharmacological treatment approaches for diabetic dyslipidaemia include both glucose and lipid lowering drugs. Some diabetes glycaemic control agents have been shown to influence lipid levels as well as glucose metabolism.1 The effects of some antihyperglycaemic drugs on lipoproteins are summarised in Table...
The main drugs used for the treatment of dyslipidemia are: Statins. Statins are by far the most used pharmacological treatment for dyslipidemia. Statins reduce the synthesis of cholesterol in the liver by competitively inhibiting 3-hydroxy-3-methylglutaril-coenzyme A (HMG-CoA)reductaseactivity. The...
Understanding the underlying pathophysiology and the principles of pharmacological and non-pharmacological therapeutic interventions can be of value in the appropriate management of dyslipidemia in the HIV-infected patient.doi:10.1007/s11883-015-0493-xSekhar...
Different guidelines have been developed to provide recommendations and targets for the pharmacological treatment of dyslipidemia (seeTable.Recommendations and Targets for Pharmacologically Treating Dyslipidemia), such as the U.S. Department of Veterans Affairs and Department of Defense (VA/DoD), the Europ...
Although the first line of treatment for dyslipidemia is dietary and lifestyle intervention, this alone is insufficient for many children to lower their LDL cholesterol, and many children will require pharmacological intervention. Pharmacotherapy options are as follows (summarised in Table below): ...
nonpharmacological approaches, such as weight loss, lifestyle modifications and bariatric surgery, as well as pharmacologic targets aimed at improving insulin sensitivity. A better understanding of the pathogenesis of insulin resistance will allow the development of newer treatment options that can address...
dyslipidemia in this population. The achievement and reduction of dyslipidemia to optimal levels in CKD stages 1–4 can be most successfully accomplished using a multifactorial health care team approach that includes comprehensive assessment and intervention using lifestyle, dietary, and pharmacological ...
Lifestyle and pharmacological interventions are the most important Financial disclosure statement LW has nothing to declare; KGP has received research support by Genzyme, Merck Sharp & Dohme, and Novartis and honoraria for presentations, advisory board activities or DMC activities by Aegerion, Amgen, ...
Visceral Obesity and Its Shared Role in Cancer and Cardiovascular Disease: A Scoping Review of the Pathophysiology and Pharmacological Treatments Int J Mol Sci, 21 (23) (2020) Google Scholar 15 Pon D., A. Abe, E.K. Gupta A review of statin use and prostate cancer Curr Atheroscler Rep, ...